Kyoto University and Astellas Inaugurate “Alliance Station” with Aim of Realizing Advanced Medical Treatments




Kyoto and Tokyo, June 5, 2017  – Kyoto University (President: Juichi Yamagiwa) and Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the inauguration of Alliance Station (A-Station), a new open innovation scheme at Kyoto University, and the establishment of Alliance Laboratory for Advanced Medical Research as a framework for the  implementation of its activities in Graduate School of Medicine Kyoto University.

There are still many unmet medical needs in the world including those of intractable diseases and rare diseases. Due to their complexity and rarity, mechanisms of these diseases are more difficult to be clarified, and drug discovery for these diseases requires an understanding of disease pathologies in humans. Thus, researches using blood and other clinical samples to identify molecules and cells critically associated with patients’ diseases, and those determining patient stratification are being highly demanded. In order to exploit findings of these studies and deliver innovative drugs to patients as soon as possible, efficient and in-depth research collaborations between academia and pharmaceutical company are needed in situations close to the clinical setting and diseases.

A-Station has been established to further accelerate drug discovery research through evolution of the open innovation system established by Kyoto University and Astellas in the AK project*1 where clinical and basic research of the university and drug discovery research of the company are closely linked in a timely manner. A-Station is a new platform for collaboration between industry and academia and under this scheme, Kyoto University and Astellas will conduct joint research projects in all therapeutic areas in a prompt and flexible manner.

Kyoto University and Astellas will accelerate search for drug seeds and launch of drugs that could address unmet medical needs as well as inventing new technologies for predicting clinical validation.


The 3rd Kyoto Course and Symposium on Bioinformatics for Next Generation Sequencing with Applications in Human Genetics

The 3rd Kyoto Course and Symposium on Bioinformatics for Next Generation Sequencing with Applications in Human Genetics


The 3-day course will provide a practical introduction to analysis of next generation sequencing data, including handling of raw data as well as their application to the study of human diseases. This year, we have placed special emphasis on the analysis of complex traits using NGS data (e.g. whole genome/exome, epigenome and target sequencing of the HLA loci) in addition to the technical challenges of analysis such as data manipulation and variant annotation.

Monday, March 16 – Wednesday, March 18, 2015 9:00 – 17:00

Seminar Room (1st floor), South Research Building
Kyoto University Graduate School of Medicine
53, Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Introduction to Human Genetics, Data Manipulation and Variant Calling (SNV, CNV), Variant Annotation and Disease Gene Annotation, Statistical Tests, Methods for Complex Analysis, Epigenomics Analysis, HLA Analysis, Functional prediction

Course instructors:
Mathieu Bourgey (McGill Univ., Canada), Guillaume Bourque (McGill Univ., Canada), Atsuko Imai (Osaka Univ., Japan), Mark Lathrop (McGill Univ., Canada), Liming Liang (Harvard Univ., USA), Jacek Majewski (McGill Univ., Canada), Jurg Ott (Chinese Academy of Sciences, PRC & Rockefeller Univ., USA), Shamil Sunyaev (Harvard Univ., USA), Joseph D. Terwilliger (Columbia Univ., USA), Daniel E. Weeks (Univ. of Pittsburgh, USA), Ryo Yamada (Kyoto Univ., Japan), Wanling Yang (Univ. of Hong Kong, Hong Kong)

The course is aimed principally at advanced doctoral students or post-doctoral researchers who need to apply next-generation sequencing in medical studies. Applicants will be selected based on description of their background and future research interests, to be submitted when applying for the course. The number of attendees will be limited to approximately 40. Those who intend to participate in the training course are requested to fill out the Course Application Form on our website.

Course fee:
Academic: 30,000 yen     Non-academic: 60,000 yen

Application deadline: February 15, 2015
The selection results will be announced by February 20. Details of the payment of the course fee will be informed to successful candidates.



The course will be followed by a 2-day symposium with invited international speakers to provide perspectives on recent advances in medical genomics. The symposium will be open to the course attendees and others from the scientific community. Admission to the symposium is free of charge, but advance registration is recommended.

Thursday, March 19, 2015 10:00 – 17:00
Friday, March 20, 2015 10:00 – 12:30

Memorial Auditorium, Kyoto University Graduate School of Medicine
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan

Genomics/Epigenomics, Analysis of Rare and Complex Diseases, High Speed Computation for Life Big Data, Application of Genomic Studies to Drug Discovery, Pathway and Network
Analysis, BioBank, Epidemiology

Symposium speakers:
Florence Demenais (Inserm, France), David Langlais (McGill Univ., Canada), Liming Liang (Harvard Univ., USA), Samantha Murphy (UK Biobank, UK), Hui Huck Ng (Genome Inst. of Singapore, Singapore), Anavaj Sakuntabhai (Inst. Pasteur, France), Philippe Sanseau (GlaxoSmithKline, UK), Shoji Tsuji (The Univ. of Tokyo, Japan), Daniel E. Weeks (Univ. of Pittsburgh, USA), Wanling Yang (Univ. of Hong Kong, Hong Kong)



Center for Genomic Medicine, Kyoto University Graduate School of Medicine

National Taiwan University & Kyoto University Symposium 2013 (Medicine Session) held at National Taiwan University (December 19-20, 2013)

The National Taiwan University & Kyoto University Symposium 2013 – Medicine Session was held at National Taiwan University (NTU) on December 19 – 20, 2013. About 100 members from both universities gathered over the two-day period of the symposium with the aim of raising the international presence of the institutions, widely communicating research achievements, and promoting international cooperative research.

The symposium represents part of Kyoto University’s efforts under its new international strategy, which was formulated in June 2013 to promote the further development of the university as a world-class institution of higher learning, and to consolidate its global position as a true leading university.

The first day of the Medicine session opened with address by Professor Nagahiro Minato, Dean of Graduate School of Medicine, Kyoto University. After the opening address, the parting scholars divided into two rooms for 6 sub-sessions including A. Immunology, B. Stem Cell Biology, C. Public health and Epidemiology, D. Imaging Technology and Application, E. Genomic Medicine and Cell Biology, F. Clinical Science, and engaged in the enthusiastic discussion on advanced research activities. Poster presentation by young researchers and graduate students from Kyoto University brought an fruitful discussion with NTU’s scholars.

The symposium concluded with closing remarks by Professor Shan-Chwen Chang, Dean of College of Medicine, National Taiwan University. After the closing, wrap-up meeting for the medicine session was organized to achieve the consent on future plans for collaboration research and young as well as students exchange programs. Plans are currently being made for a follow-up symposium to be held at Kyoto University in September 2014, inviting members from NTU.

Medicine Session:

1 2 3